Hikma moves into Morocco with $111M deal

Jordan's Hikma Pharmaceuticals has made its first foray into Morocco with a $111 million deal for controlling interest in Promopharm, the country's 9th-largest drugmaker with 200 branded generics and in-licensed products. The company plans to introduce about 20 Hikma products into the market as well. Report

Suggested Articles

With U.S. presidential and congressional campaigns in full swing, it’s not just Americans anxiously awaiting the results of the upcoming elections.

Sun Pharma has recalled one lot of its generic metformin after finding high levels of the probable carcinogen NDMA in tested lots.

Six months after WHO declared a pandemic, the list of drugs proven to work against the virus remains short. Now, Fujifilm has added its drug Avigan.